All In Biotech

Company · ALPMY

Astellas

Includes drugs filed under related and acquired sponsor names. Trials are searched under: Astellas Pharma Inc; Astellas Pharma Global Development, Inc..

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

27

15 still marketed

Novel approvals

15

Approvals since 2021

23

Originals and new uses

Phase 3 trials

175

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

  • Xtandi new use Jul 24, 2026
  • Xtandi new use Jul 24, 2026
  • Padcev new use Priority reviewJul 10, 2026
  • Padcev new use Priority reviewNov 21, 2025
  • Vyloy new use OrphanJun 6, 2025
  • Izervay new use Feb 12, 2025
  • Vyloy approved NovelPriority reviewOrphanOct 18, 2024
  • Padcev new use Priority reviewDec 15, 2023
  • Padcev new use Priority reviewDec 15, 2023
  • Cresemba new use Priority reviewOrphanDec 8, 2023

Drugs in development (13)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline
  • folinic acidPhase 34 trials

    Astellas · Unresectable Metastatic Colorectal Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer

  • pudexacianinium chlorideASP5354Phase 32 trials

    Astellas · Intraoperative Ureter Visualization, Abdominolpelvic Surgery

  • RoxadustatFG-4592, ASP1517Phase 32 trials

    Astellas · Chronic Kidney Disease, Renal Anemia, Myelodysplastic Syndromes

  • SetidegrasibASP3082Phase 32 trials

    Astellas · Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma

  • ASP2138Phase 31 trial

    Astellas · Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma

  • XNW27011ASP546CPhase 22 trials

    Astellas · Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic

  • ASP2246Phase 21 trial

    Astellas · Chronic Ischemic Stroke

  • ASP2767Phase 21 trial

    Astellas · Glaucoma

  • ASP2957MyoAAV3.8 engineered capsid - myosin heavy chain kinase 7 - human myotubularin, MyoAAV3.8-MHCK7-hMTM1Phase 21 trial

    Astellas · X-linked Myotubular Myopathy

  • ASP2998Phase 21 trial

    Astellas · Locally Advanced or Metastatic Malignant Solid Tumors

  • ASP388BPhase 21 trial

    Astellas · Locally Advanced or Metastatic Solid Tumors

  • ASP5541PRL-02Phase 21 trial

    Astellas · Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer

  • Astellas · Intestine Transplantation, Kidney Transplantation, Lung Transplantation

Recruiting Phase 3 trials

Largest first.

Marketed drugs (15)

Newest FDA action first.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.